Acute candesartan cilexetil outcomes stroke trial (ACCOST)

Trial Profile

Acute candesartan cilexetil outcomes stroke trial (ACCOST)

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms ACCOST
  • Most Recent Events

    • 07 Oct 2009 Actual end date (Jun 2006) added as reported by ISRCTN: Current Controlled Trials.
    • 07 Oct 2009 Additional lead trial centres and investigators identified as reported by ISRCTN: Current Controlled Trials.
    • 07 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top